← Evidence map

ArticleFrontiers in psychiatry2024

Using cerebrospinal fluid biomarkers to diagnose Alzheimer's disease: an Australian perspective.

Dhamidhu Eratne et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

3 papers cite it

2024
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 39703457